Standout Papers

Reactive oxygen species-powered cancer immunotherapy: Current status and challenges 2023 2026 202498
  1. Reactive oxygen species-powered cancer immunotherapy: Current status and challenges (2023)
    Mengying He, Tao Xu et al. Journal of Controlled Release

Immediate Impact

9 from Science/Nature 53 standout
Sub-graph 1 of 21

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
3 intermediate papers

Works of Dawei Ding being referenced

Immunotherapy and Prevention of Cancer by Nanovaccines Loaded with Whole‐Cell Components of Tumor Tissues or Cells
2021
Novel Self-assembly Endows Human Serum Albumin Nanoparticles with an Enhanced Antitumor Efficacy
2013

Author Peers

Author Last Decade Papers Cites
Dawei Ding 422 361 377 29 1.1k
Alexandros Marios Sofias 477 469 427 30 1.2k
Shiran Ferber 396 438 292 21 1.1k
Md. Nazir Hossen 394 474 390 35 1.2k
Min Mu 542 328 330 43 1.1k
Qilin Li 420 462 353 52 1.3k
Sunny Kumar 377 471 462 32 1.2k
Wayne Ngo 481 437 471 17 1.0k
Chunxiong Zheng 451 638 306 32 1.3k
Guilei Ma 516 358 444 36 1.2k
Anusha Pusuluri 454 488 361 14 1.2k

All Works

Loading papers...

Rankless by CCL
2026